Integer (ITGR) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Integer Revenue Highlights


Latest Revenue (Y)

$1.60B

Latest Revenue (Q)

$753.01M

Main Segment (Y)

Medical Segment

Main Geography (Y)

UNITED STATES

Integer Revenue by Period


Integer Revenue by Year

DateRevenueChange
2023-12-31$1.60B16.03%
2022-12-31$1.38B12.70%
2021-12-31$1.22B13.75%
2020-12-31$1.07B-14.68%
2019-12-31$1.26B3.55%
2018-12-28$1.22B-16.89%
2017-12-29$1.46B5.42%
2016-12-30$1.39B73.26%
2016-01-01$800.41M16.38%
2015-01-02$687.79M3.59%
2014-01-03$663.95M2.75%
2012-12-28$646.18M13.60%
2011-12-30$568.82M6.64%
2010-12-31$533.42M2.22%
2010-01-01$521.82M-4.54%
2009-01-02$546.64M71.50%
2007-12-28$318.75M17.56%
2006-12-29$271.14M12.46%
2005-12-30$241.10M20.48%
2004-12-31$200.12M-7.51%
2004-01-02$216.37M29.33%
2003-01-03$167.30M23.40%
2001-12-28$135.57M38.64%
2000-12-29$97.79M23.42%
1999-12-31$79.23M-

Integer generated $1.60B in revenue during NA 2023, up 16.03% compared to the previous quarter, and up 131.41% compared to the same period a year ago.

Integer Revenue by Quarter

DateRevenueChange
2024-06-28$753.01M81.54%
2024-03-29$414.80M0.40%
2023-12-31$413.15M2.09%
2023-09-29$404.69M1.16%
2023-06-30$400.04M5.61%
2023-03-31$378.79M1.71%
2022-12-31$372.42M8.68%
2022-09-30$342.68M-2.11%
2022-07-01$350.08M12.60%
2022-04-01$310.91M-0.67%
2021-12-31$313.01M2.44%
2021-10-01$305.57M-2.07%
2021-07-02$312.02M7.42%
2021-04-02$290.47M8.00%
2020-12-31$268.96M13.99%
2020-10-02$235.94M-1.74%
2020-07-03$240.12M-26.89%
2020-04-03$328.43M0.86%
2019-12-31$325.64M7.26%
2019-09-27$303.59M-3.38%
2019-06-28$314.19M-0.15%
2019-03-29$314.68M3.84%
2018-12-28$303.03M-0.67%
2018-09-28$305.09M-2.98%
2018-06-29$314.46M-17.62%
2018-03-30$381.75M-2.24%
2017-12-29$390.48M7.48%
2017-09-29$363.31M0.16%
2017-06-30$362.72M5.01%
2017-03-31$345.41M-3.94%
2016-12-30$359.59M3.76%
2016-09-30$346.57M-0.52%
2016-07-01$348.38M4.86%
2016-04-01$332.24M4.62%
2016-01-01$317.57M116.57%
2015-10-02$146.64M-16.15%
2015-07-03$174.89M8.41%
2015-04-03$161.32M-4.95%
2014-12-31$169.73M-1.15%
2014-09-30$171.70M-0.22%
2014-06-30$172.08M-1.26%
2014-03-31$174.28M-1.32%
2014-01-03$176.62M5.30%
2013-09-27$167.73M-2.10%
2013-06-28$171.33M15.56%
2013-03-29$148.26M-6.86%
2012-12-28$159.19M-1.34%
2012-09-28$161.34M-3.13%
2012-06-29$166.55M4.68%
2012-03-30$159.10M12.25%
2011-12-30$141.75M7.61%
2011-09-30$131.72M-10.10%
2011-07-01$146.52M-1.55%
2011-04-01$148.83M11.81%
2010-12-31$133.11M4.41%
2010-10-01$127.49M-9.45%
2010-07-02$140.79M6.64%
2010-04-02$132.03M4.94%
2010-01-01$125.81M3.57%
2009-10-02$121.47M-9.84%
2009-07-03$134.72M-3.64%
2009-04-03$139.82M-4.63%
2009-01-02$146.60M7.60%
2008-09-26$136.24M-3.82%
2008-06-27$141.65M15.96%
2008-03-28$122.15M44.71%
2007-12-28$84.42M-

Integer generated $753.01M in revenue during Q2 2024, up 81.54% compared to the previous quarter, and up 198.80% compared to the same period a year ago.

Integer Revenue Breakdown


Integer Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21Dec 20Dec 19
Non-Medical Segment$43.33M$46.55M$38.45M$35.46M$58.41M
Medical Segment$1.55B$1.33B$1.18B$1.04B$1.20B

Integer's latest annual revenue breakdown by segment (product or service), as of Dec 23: Medical Segment (97.29%), and Non-Medical Segment (2.71%).

Quarterly Revenue by Product

Product/ServiceJun 24Mar 24Dec 23Sep 23Jun 23Mar 23Sep 22Jul 22Apr 22Oct 21Jul 21Apr 21Oct 20Jul 20Apr 20Dec 19Sep 19Jun 19Mar 19Dec 18
Medical Segment$427.38M$407.21M$404.06M$395.90M$389.11M$364.27M$330.91M$339.83M$302.03M$296.12M$301.63M$282.96M$227.68M$231.38M$318.26M$311.65M$289.42M$297.53M$301.07M$290.23M
Non-Medical Segment$8.82M$7.59M$9.09M$8.79M$10.93M$14.52M$11.77M$10.25M$8.88M$9.45M$10.40M$7.50M$8.26M$8.73M$10.16M$13.99M$14.16M$16.66M$13.60M$12.81M

Integer's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: Medical Segment (97.98%), and Non-Medical Segment (2.02%).

Integer Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23Dec 22Dec 21Dec 20Dec 19
UNITED STATES$897.43M$762.13M$671.50M$596.80M$698.47M
Rest Of World$501.25M$423.74M$372.44M$321.74M$341.34M
PUERTO RICO$108.42M$114.08M$110.16M$96.05M$154.64M

Integer's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (59.55%), Rest Of World (33.26%), and PUERTO RICO (7.19%).

Integer Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
BRKRBruker$2.96B$800.70M
ITGRInteger$1.60B$753.01M
CNMDCONMED$1.24B$332.10M
LIVNLivaNova$1.15B$318.60M
IRTCiRhythm$492.68M$148.05M
NVRONevro$425.17M$101.90M
GKOSGlaukos$314.71M$95.69M
ESTAEstablishment Labs$165.15M$44.12M
KIDSOrthoPediatrics$148.73M$52.80M
LUNGPulmonx$68.67M$20.78M
IRMDIRadimed$65.56M$17.93M
NPCENeuroPace$65.42M$18.12M
OFIXOrthofix Medical$100.00K$198.62M

ITGR Revenue FAQ


Integer's yearly revenue for 2023 was $1.6B, representing an increase of 16.03% compared to 2022. The company's yearly revenue for 2022 was $1.38B, representing an increase of 12.70% compared to 2021. ITGR's yearly revenue for 2021 was $1.22B, representing an increase of 13.75% compared to 2020.

Integer's quarterly revenue for Q2 2024 was $753.01M, a 81.54% increase from the previous quarter (Q1 2024), and a 88.23% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $414.8M, a 0.40% increase from the previous quarter (Q4 2023), and a 9.51% increase year-over-year (Q1 2023). ITGR's quarterly revenue for Q4 2023 was $413.15M, a 2.09% increase from the previous quarter (Q3 2023), and a 10.94% increase year-over-year (Q4 2022).

Integer's revenue growth rate for the last 3 years (2021-2023) was 30.76%, and for the last 5 years (2019-2023) was 26.91%.

Integer's revenue streams in c 23 are Non-Medical Segment, and Medical Segment. Non-Medical Segment generated $43.33M in revenue, accounting 2.71% of the company's total revenue, down -6.90% year-over-year. Medical Segment generated $1.55B in revenue, accounting 97.29% of the company's total revenue, up 16.83% year-over-year.

For the fiscal year ending Dec 23, the largest source of revenue of Integer was Medical Segment. This segment made a revenue of $1.55B, representing 97.29% of the company's total revenue.